News

Colonoscopy's Efficacy Confirmed in Average-Risk Adults


 

FROM THE ANNUAL DIGESTIVE DISEASE WEEK

In contrast, for distal cancers the protective benefit of colonoscopy extended beyond 7 years: Screening colonoscopy provided a significant 42% cancer-rate reduction, compared with no screening, more than 7 years out.

The analysis also showed that the statistically significant protective benefit from polypectomy lasted for just 3 years for all cancer locations, with a 52% protection rate compared with no screening. For distal cancers a significant protective effect lasted for 5 years, but for proximal cancers polypectomy did not provide significant protection, even during the first 3 years after the procedure.

An additional multivariate analysis showed cumulative protection from multiple colonoscopies. A single screening colonoscopy cut the rate of incident cancers, both proximal and distal, by a statistically significant 47%, but two colonoscopies cut the risk by 59% and three or more colonoscopies cut the risk by 64%.

Dr. Lochhead said that he had no disclosures.

Pages

Recommended Reading

Meta-Analysis Links Acid Suppression to C. difficile Risk
MDedge Internal Medicine
Norovirus Outbreak Traced to Reusable Grocery Bag
MDedge Internal Medicine
Antibiotics/Probiotics Helpful in Irritable Bowel Syndrome
MDedge Internal Medicine
Fatty Acids in Fish May Lower Liver Cancer Risk
MDedge Internal Medicine
Many Patients Without Acid Reflux Stay on PPIs
MDedge Internal Medicine
Terlipressin Shows Some Benefit in Hepatorenal Syndrome
MDedge Internal Medicine
UnitedHealthcare to Use AGA Registry Data
MDedge Internal Medicine
Docs Need Primer on Long-Term Effects of Chemotherapy
MDedge Internal Medicine
Hiatal Hernia History? Consider Gastric Volvulus
MDedge Internal Medicine
Lymphadenectomy Underused in GI Cancer Surgery
MDedge Internal Medicine